Skip to main content
. Author manuscript; available in PMC: 2015 Sep 18.
Published in final edited form as: ChemMedChem. 2011 Jan 21;6(2):334–342. doi: 10.1002/cmdc.201000490

Table 1.

Anti-TB activity of compounds 3a–w, 4–6 against M. tuberculosis strain H37Rv.

Compd MICMABA[a]
[µg mL−1]
MICBD[b]
[µg mL−1]
IC50 Vero cells[c]
[µg mL−1]
Compd MICMABA
[µg mL−1]
MICBD
[µg mL−1]
IC50 Vero cells
[µg mL−1]
3a 0.5 1.0 8.0 3n >128 nt nt
3b >128 >128 nt[d] 3o 4.0 nt nt
3c >128 >128 nt 3p 4.0 nt nt
3d >128 nt nt 3q 0.5 nt nt
3e >128 nt nt 3r 0.5 1.0 >64
3 f 64 nt nt 3s 8.0 nt nt
3g 8.0 nt nt 3t >128 nt nt
3h 0.25 0.25 >64 3u 4.0 nt nt
3i 2.0 2.0 16 3v 8.0 nt nt
3j 0.5 nt nt 3w >128 nt nt
3k 0.5 nt nt 4 2.0 nt nt
3l 0.25 1.0 8.0 5 1.0 nt nt
3m 0.25 0.5 4.0 6 >128 nt nt
INH[e] 0.04 nt nt
[a]

The lowest concentration of drug leading to at least a 90% reduction of bacterial growth signal by microplate Alamar Blue assay (MABA); values reported are the average of three individual measurements;

[b]

The lowest concentration of drug preventing visible bacterial growth in a 5 mL Tween-free Middlebrook broth dilution (BD) culture; values reported are the average of three individual measurements;

[c]

Cytotoxicity against Vero cells;

[d]

Not tested;

[e]

Isoniazid.